Abivax S.A. (ADR)
General ticker "ABVX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.9B (TTM average)
Abivax S.A. (ADR) follows the US Stock Market performance with the rate: 52.3%.
Estimated limits based on current volatility of 2.9%: low 110.40$, high 116.95$
Factors to consider:
- Total employees count: 1000 as of 2024
Short-term ABVX quotes
Long-term ABVX plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €4.62MM | €10.79MM | €0.00MM |
| Operating Expenses | €132.00MM | €183.78MM | €240.73MM |
| Operating Income | €-127.38MM | €-172.98MM | €-240.73MM |
| Non-Operating Income | €-24.86MM | €-3.26MM | €-79.43MM |
| Interest Expense | €13.83MM | €4.18MM | €27.39MM |
| R&D Expense | €103.18MM | €146.53MM | €170.75MM |
| Income(Loss) | €-152.23MM | €-176.24MM | €-320.16MM |
| Taxes | €-4.49MM | €0.00MM | €2.68MM |
| Profit(Loss)* | €-147.74MM | €-176.24MM | €-322.84MM |
| Stockholders Equity | €196.01MM | €40.58MM | €455.01MM |
| Assets | €327.06MM | €205.23MM | €584.09MM |
| Operating Cash Flow | €-100.01MM | €-154.07MM | €-155.69MM |
| Capital expenditure | €0.27MM | €0.64MM | €0.14MM |
| Investing Cash Flow | €-10.49MM | €15.76MM | €-13.18MM |
| Financing Cash Flow | €340.57MM | €28.21MM | €531.94MM |
| Earnings Per Share** | €-3.43 | €-2.80 | €-4.64 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.